Paxman: CIPN included in a study - Redeye

Paxman announced yesterday that the Paxman Limb Cryocompression System (PLCS) would be used in a prospective study looking at the prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN). This is as we see it real progress in this field, and if successful, the study would prove a significant step forward in the CIPN area.

Länk till analysen i sin helhet: https://www.redeye.se/research/863643/paxman-cipn-included-in-a-study?utm_source=finwire&utm_medium=RSS